The Influence of Bone Allograft Particle Sizes on the Quantity and Quality of New Bone Formation in Grafted Extraction Sockets and Edentulous Ridges
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Mar 12, 2018
Trial Information
Current as of July 05, 2025
Completed
Keywords
ClinConnect Summary
This study is a prospective, two-arm, randomized trial that will evaluate and compare the bone healing following ridge preservation of extraction sockets (RP, Arms 1 and 2) or lateral ridge augmentation of edentulous sites (RA, Arms 3 and 4) using either small particle (SP) or large particle (LP) mineralized cortico-cancellous bone allografts in a total of 48 patients (12 in each arm).
Study approval was obtained from the university's institutional review board. Qualifying participants and defects are randomized following a computerized permutation block to receive either LP or SP allograf...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English speaking
- • At least 18 years old
- • Must be a patient of the UAB Dental School
- • Able to read and understand informed consent document
- • Need for implants to replace missing tooth or teeth in at least one quadrant of the mouth.
- • Hopeless tooth or teeth planned to be replaced with dental implant(s)_socket with residual 4 walls following minimally invasive tooth extraction (a dehiscence of \<3mm may be included) or insufficient alveolar ridge width for endosseous implant placement defined as 5mm or less as determined by bone sounding and cone beam computed tomography (CBCT) scan.
- • Patient and/or guardian is willing and able to comply with the preoperative and postoperative diagnostic and clinical evaluations required.
- Exclusion Criteria:
- • Non-English speaking
- • Less than 18 years old
- • Smokers/tobacco users (\>10 cigarettes/day)
- • Patients with systemic pathologies or conditions contraindicating oral surgical procedures or adversely affecting wound healing
- • Patients with significant medical conditions or habits expected to interfere with bony healing.
- • Patient is a poor compliance risk (i.e., poor oral hygiene, history of alcohol or drug abuse)
- • Bone dehiscence of \>4mm following tooth extraction or Vertical loss of bone at edentulous ridge
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Patients applied
Trial Officials
Ramzi V Abou-Arraj, DDS, MS
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials